Clinical Trial Update: Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing arzoxifene with raloxifene in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• Arzoxifene (arzoxifene)
• Raloxifene (raloxifene)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED